AGIOS PHARMACEUTICALS INC
AGIO·00847X104·US·Common Stock·Healthcare - Biotechnology-13D/G
AGIO (AGIOS PHARMACEUTICALS INC) is held by 126 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($194.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($192.3M), STATE STREET CORP ($113.7M). Net institutional sentiment: Mixed. In Q1 2026, 2 members of Congress and 60 funds bought AGIO.
126
Holders
(10 Elite)
$1.6B
Total Value
48% (124)
Consensus
60 buying - 64 selling
13F: Insider & Congress:
Who's Trading
ActivistDED. E. Shaw & Co., L.P.5.1%Jul 2, 2026
ActivistARArmistice Capital, LLC4.6%May 15, 2026
InsiderGBGoff BrianSell $229KApr 2, 2026
InsiderGBGoff BrianSell $433KApr 2, 2026
InsiderGSGheuens SarahSell $102KApr 2, 2026
InsiderJCJones CeciliaSell $109KApr 2, 2026
Showing 1-20 of 138
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer